|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4510245A
(en)
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
JPS59156299A
(ja)
|
1983-02-28 |
1984-09-05 |
Noda Sangyo Kagaku Kenkyusho |
Ｎ−アセチルヘキソサミンの定量法及びその定量用試薬
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4534972A
(en)
|
1983-03-29 |
1985-08-13 |
Miles Laboratories, Inc. |
Protein compositions substantially free from infectious agents
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DD266710A3
(de)
|
1983-06-06 |
1989-04-12 |
Ve Forschungszentrum Biotechnologie |
Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
EP0154316B1
(en)
|
1984-03-06 |
1989-09-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified lymphokine and production thereof
|
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4968615A
(en)
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
|
US5045468A
(en)
*
|
1986-12-12 |
1991-09-03 |
Cell Enterprises, Inc. |
Protein-free culture medium which promotes hybridoma growth
|
|
US5476996A
(en)
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US6048728A
(en)
*
|
1988-09-23 |
2000-04-11 |
Chiron Corporation |
Cell culture medium for enhanced cell growth, culture longevity, and product expression
|
|
EP0435911B1
(en)
|
1988-09-23 |
1996-03-13 |
Cetus Oncology Corporation |
Cell culture medium for enhanced cell growth, culture longevity and product expression
|
|
EP0401384B1
(en)
|
1988-12-22 |
1996-03-13 |
Kirin-Amgen, Inc. |
Chemically modified granulocyte colony stimulating factor
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
US5110913A
(en)
*
|
1990-05-25 |
1992-05-05 |
Miles Inc. |
Antibody purification method
|
|
US5096816A
(en)
*
|
1990-06-05 |
1992-03-17 |
Cetus Corporation |
In vitro management of ammonia's effect on glycosylation of cell products through pH control
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
AU665190B2
(en)
|
1990-07-10 |
1995-12-21 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
WO1992009690A2
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
|
ATE439435T1
(de)
|
1991-03-01 |
2009-08-15 |
Dyax Corp |
Chimäres protein mit mikroprotein mit zwei oder mehr disulfidbindungen und ausgestaltungen davon
|
|
DE69233750D1
(de)
|
1991-04-10 |
2009-01-02 |
Scripps Research Inst |
Bibliotheken heterodimerer Rezeptoren mittels Phagemiden
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
EP0666312A1
(en)
*
|
1994-02-08 |
1995-08-09 |
Wolfgang A. Renner |
Process for the improvement of mammalian cell growth
|
|
US5429746A
(en)
*
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
|
US5853714A
(en)
*
|
1995-03-27 |
1998-12-29 |
Genetics Institute, Inc. |
Method for purification of IL-12
|
|
US5641870A
(en)
*
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5705364A
(en)
*
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
|
US5721121A
(en)
*
|
1995-06-06 |
1998-02-24 |
Genentech, Inc. |
Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
|
|
US6656466B1
(en)
*
|
1995-06-06 |
2003-12-02 |
Genetech, Inc. |
Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
|
|
JP4306813B2
(ja)
*
|
1995-09-19 |
2009-08-05 |
アスビオファーマ株式会社 |
動物細胞の新規培養方法
|
|
DE69623109T2
(de)
*
|
1996-04-19 |
2002-12-12 |
Societe Des Produits Nestle S.A., Vevey |
Menschliche immortalisierte Colon-Epithelialzellen
|
|
AU5082698A
(en)
|
1996-10-23 |
1998-05-15 |
Oravax, Inc |
Heat inactivation of viruses in antibody preparations
|
|
EP0936923B1
(en)
*
|
1996-11-15 |
2003-12-17 |
Kennedy Institute Of Rheumatology |
SUPPRESSION OF TNFalpha AND IL-12 IN THERAPY
|
|
JP4031049B2
(ja)
*
|
1996-11-27 |
2008-01-09 |
ジェネンテック，インコーポレーテッド |
タンパク質精製
|
|
US6955917B2
(en)
*
|
1997-06-20 |
2005-10-18 |
Bayer Healthcare Llc |
Chromatographic method for high yield purification and viral inactivation of antibodies
|
|
IL121900A
(en)
|
1997-10-07 |
2001-12-23 |
Omrix Biopharmaceuticals Ltd |
A method for the purification of immunoglobulins
|
|
US20020045207A1
(en)
*
|
1997-10-31 |
2002-04-18 |
Lynne A. Krummen |
Glycoprotein production process
|
|
WO1999032605A1
(en)
|
1997-12-19 |
1999-07-01 |
Novo Nordisk A/S |
Method for producing heterologous proteins in eukaryotic cells on an industrial scale using nucleotide-manipulating agents
|
|
ATE321066T1
(de)
*
|
1998-05-06 |
2006-04-15 |
Genentech Inc |
Anti-her2 antikörperzusammensetzung
|
|
US6528286B1
(en)
*
|
1998-05-29 |
2003-03-04 |
Genentech, Inc. |
Mammalian cell culture process for producing glycoproteins
|
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
AU7614600A
(en)
*
|
1999-09-27 |
2001-04-30 |
Genentech Inc. |
Methods for making recombinant proteins using apoptosis inhibitors
|
|
ES2266159T3
(es)
*
|
2000-02-08 |
2007-03-01 |
Genentech, Inc. |
Mejora de la galactosilacion de glicoproteinas recombinantes.
|
|
CA2399148A1
(en)
|
2000-02-10 |
2001-08-16 |
Abbott Laboratories |
Antibodies that bind human interleukin-18 and methods of making and using
|
|
US7598055B2
(en)
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
|
EP1175931A1
(en)
*
|
2000-07-25 |
2002-01-30 |
Computer Cell Culture Center S.A. |
Integration of high cell density bioreactor operation with ultra fast on-line downstream processing
|
|
AU2001294520A1
(en)
*
|
2000-08-21 |
2002-03-04 |
Clonex Development, Inc. |
Methods and compositions for increasing protein yield from a cell culture
|
|
US6693173B2
(en)
*
|
2000-12-26 |
2004-02-17 |
Alpha Therapeutic Corporation |
Method to remove citrate and aluminum from proteins
|
|
US20030096414A1
(en)
*
|
2001-03-27 |
2003-05-22 |
Invitrogen Corporation |
Culture medium for cell growth and transfection
|
|
DE60227067D1
(de)
|
2001-05-11 |
2008-07-24 |
Kirin Pharma Kk |
Künstliches menschliches chromosom mit dem gen für die lambda-leichte kette menschlicher antikörper
|
|
DK1714982T3
(da)
*
|
2001-06-05 |
2009-05-04 |
Genetics Inst Llc |
Fremgangsmåde til rensning af stærkt anioniske proteiner
|
|
CA2455365C
(en)
*
|
2001-08-03 |
2014-07-29 |
Glycart Biotechnology Ag |
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
|
|
ES2291534T3
(es)
*
|
2001-10-02 |
2008-03-01 |
Novo Nordisk Health Care Ag |
Metodo para la produccion de proteinas recombinantes en celulas eucariotas.
|
|
ATE430580T1
(de)
*
|
2001-10-25 |
2009-05-15 |
Genentech Inc |
Glycoprotein-zusammensetzungen
|
|
IL161858A0
(en)
|
2001-11-28 |
2005-11-20 |
Sandoz Ag |
Cell culture process
|
|
WO2003059935A2
(en)
*
|
2001-12-21 |
2003-07-24 |
Immunex Corporation |
Methods for purifying protein
|
|
US20030201229A1
(en)
*
|
2002-02-04 |
2003-10-30 |
Martin Siwak |
Process for prefiltration of a protein solution
|
|
JP4460302B2
(ja)
*
|
2002-02-05 |
2010-05-12 |
ジェネンテック インコーポレイテッド |
タンパク質精製法
|
|
CA2417689C
(en)
*
|
2002-03-05 |
2006-05-09 |
F. Hoffmann-La Roche Ag |
Improved methods for growing mammalian cells in vitro
|
|
US20030190710A1
(en)
*
|
2002-03-28 |
2003-10-09 |
Devries Ruth L. |
Control of glycoforms in IgG
|
|
JPWO2003085118A1
(ja)
*
|
2002-04-09 |
2005-08-11 |
協和醗酵工業株式会社 |
抗体組成物の製造方法
|
|
RU2304587C2
(ru)
*
|
2002-06-10 |
2007-08-20 |
Гуд Байотек Копэрейшн |
СПОСОБ СЕЛЕКТИВНОГО ВЫДЕЛЕНИЯ АНТИТЕЛ IgY ИЗ ЯИЧНОГО ЖЕЛТКА ПТИЦ ОТРЯДА ГУСЕОБРАЗНЫХ (ВАРИАНТЫ)
|
|
PL376381A1
(en)
*
|
2002-07-15 |
2005-12-27 |
Immunex Corporation |
Methods and media for controlling sialylation of proteins produced by mammalian cells
|
|
CN101745112A
(zh)
*
|
2002-07-19 |
2010-06-23 |
艾博特生物技术有限公司 |
TNFα相关疾病的治疗
|
|
US6974681B1
(en)
*
|
2002-08-23 |
2005-12-13 |
Immunex Corporation |
Cell culture performance with vanadate
|
|
US7067279B1
(en)
*
|
2002-08-23 |
2006-06-27 |
Immunex Corporation |
Cell culture performance with betaine
|
|
WO2004026427A2
(en)
|
2002-09-17 |
2004-04-01 |
Gtc Biotherapeutics, Inc. |
Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
|
|
US7208585B2
(en)
*
|
2002-09-18 |
2007-04-24 |
Genencor International, Inc. |
Protein purification
|
|
US20040162414A1
(en)
|
2002-11-22 |
2004-08-19 |
Santora Ling C. |
Method for reducing or preventing modification of a polypeptide in solution
|
|
BR0317723A
(pt)
|
2002-12-23 |
2005-11-22 |
Bristol Myers Squibb Co |
Processo de cultura de células de mamìfero para a produção de proteìna
|
|
KR101088223B1
(ko)
*
|
2002-12-23 |
2011-11-30 |
브리스톨-마이어스 스큅 컴퍼니 |
단백질 생산을 위한 포유류 세포 배양 방법에서의 생산물품질 향상
|
|
SI1623019T1
(sl)
*
|
2003-05-15 |
2010-10-29 |
Wyeth Llc |
Omejeno glukozno dovajanje za živalsko celično kulturo
|
|
PL3095793T3
(pl)
*
|
2003-07-28 |
2020-09-07 |
Genentech, Inc. |
Redukcja wycieku białka A w trakcie chromatografii powinowactwa z białkiem A
|
|
GB2404665B
(en)
*
|
2003-08-08 |
2005-07-06 |
Cambridge Antibody Tech |
Cell culture
|
|
EP1673452B1
(en)
*
|
2003-10-10 |
2015-12-23 |
Novo Nordisk Health Care AG |
Method for large-scale production of a polypeptide in eukaryote cells
|
|
AU2004286938B2
(en)
*
|
2003-10-27 |
2011-06-30 |
Wyeth |
Removal of high molecular weight aggregates using hydroxyapatite chromatography
|
|
US8084032B2
(en)
|
2004-01-21 |
2011-12-27 |
Ajinomoto Co., Inc. |
Purification method which prevents denaturation of an antibody
|
|
SE0400886D0
(sv)
*
|
2004-04-02 |
2004-04-02 |
Amersham Biosciences Ab |
Process of purification
|
|
US20060127950A1
(en)
*
|
2004-04-15 |
2006-06-15 |
Massachusetts Institute Of Technology |
Methods and products related to the improved analysis of carbohydrates
|
|
ES2339953T5
(es)
|
2004-05-04 |
2020-05-06 |
Novo Nordisk Healthcare Ag |
Glicoformas de factor VII ligadas a O y método de fabricación
|
|
US7294484B2
(en)
|
2004-08-27 |
2007-11-13 |
Wyeth Research Ireland Limited |
Production of polypeptides
|
|
KR101238798B1
(ko)
*
|
2004-09-30 |
2013-03-04 |
바이엘 헬스케어, 엘엘씨 |
생물학적 분자의 통합된 연속 제조를 위한 장치 및 방법
|
|
US20060094104A1
(en)
|
2004-10-29 |
2006-05-04 |
Leopold Grillberger |
Animal protein-free media for cultivation of cells
|
|
JP2006143601A
(ja)
*
|
2004-11-16 |
2006-06-08 |
Yamato Yakuhin Kk |
血液粘度低下剤
|
|
US8728828B2
(en)
*
|
2004-12-22 |
2014-05-20 |
Ge Healthcare Bio-Sciences Ab |
Purification of immunoglobulins
|
|
JP5523674B2
(ja)
|
2005-02-11 |
2014-06-18 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
植物タンパク質加水分解産物を含有する血清フリーの細胞培養液におけるポリペプチドの生産
|
|
KR101482791B1
(ko)
*
|
2005-03-11 |
2015-01-21 |
와이어쓰 엘엘씨 |
약한 분배성 크로마토그래피법
|
|
JP2008535913A
(ja)
|
2005-04-11 |
2008-09-04 |
メダレックス インコーポレーティッド |
タンパク質精製方法
|
|
WO2006113743A2
(en)
*
|
2005-04-18 |
2006-10-26 |
Massachusetts Institute Of Technology |
Compositions and methods for rna interference with sialidase expression and uses thereof
|
|
US7247457B2
(en)
*
|
2005-04-26 |
2007-07-24 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Detection and identification of enteroviruses by semi-nested amplification of the enterovirus VP1 protein
|
|
KR20080032065A
(ko)
*
|
2005-06-03 |
2008-04-14 |
제넨테크, 인크. |
푸코실화 수준이 조절된 항체의 생성 방법
|
|
EP1909831A4
(en)
*
|
2005-06-14 |
2013-02-20 |
Amgen Inc |
SELF-BUFFING PROTEIN FORMULATIONS
|
|
EA201100177A1
(ru)
*
|
2005-06-17 |
2011-06-30 |
Элан Фарма Интернэшнл Лимитед |
СПОСОБЫ ОЧИСТКИ АНТИТЕЛ К β-АМИЛОИДУ
|
|
HUE038947T2
(hu)
*
|
2005-08-26 |
2018-12-28 |
Ares Trading Sa |
Eljárás glikozilált béta-interferon elõállítására
|
|
PE20070796A1
(es)
*
|
2005-10-24 |
2007-08-15 |
Wyeth Corp |
Metodo de produccion proteica utilizando compuestos anti-senescencia
|
|
EP2495308A1
(en)
*
|
2005-12-08 |
2012-09-05 |
Amgen Inc. |
Improved production of glycoproteins using manganese
|
|
US20070190057A1
(en)
*
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
|
EP2738178A1
(en)
*
|
2006-04-05 |
2014-06-04 |
AbbVie Biotechnology Ltd |
Antibody purification
|
|
US7851438B2
(en)
*
|
2006-05-19 |
2010-12-14 |
GlycoFi, Incorporated |
Erythropoietin compositions
|
|
US20100234577A1
(en)
*
|
2006-06-14 |
2010-09-16 |
Smithkline Beecham Corporation |
Methods for purifying antibodies using ceramic hydroxyapatite
|
|
WO2008007280A2
(en)
|
2006-06-28 |
2008-01-17 |
Koninklijke Philips Electronics N.V. |
Assay system and method
|
|
DK2041270T3
(da)
|
2006-07-13 |
2014-01-27 |
Wyeth Llc |
Fremstilling af glycoproteiner
|
|
ES2755386T5
(es)
*
|
2006-08-28 |
2023-04-05 |
Ares Trading Sa |
Proceso para la purificación de proteínas que contienen fragmentos Fc
|
|
CL2007002615A1
(es)
*
|
2006-09-08 |
2008-04-18 |
Wyeth Corp |
Metodos para aislar o purificar un producto que comprende poner el producto enlazado en contacto con al menos una solucion de lavado que comprende arginina y luego eluir el producto; y dicho producto.
|
|
US8911964B2
(en)
*
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
EP2500413A1
(en)
*
|
2006-09-13 |
2012-09-19 |
Abbott Laboratories |
Cell culture improvements
|
|
US10982250B2
(en)
*
|
2006-09-18 |
2021-04-20 |
Genentech, Inc. |
Methods of protein production
|
|
WO2008036899A2
(en)
|
2006-09-22 |
2008-03-27 |
Amgen Inc. |
Methods for removing viral contaminants during protein purification
|
|
CA2666317C
(en)
*
|
2006-11-03 |
2013-08-06 |
Wyeth |
Glycolysis-inhibiting substances in cell culture
|
|
WO2008068879A1
(en)
|
2006-12-06 |
2008-06-12 |
Jcr Pharmaceuticals Co., Ltd. |
Method for production of human erythropoietin
|
|
US8163886B2
(en)
|
2006-12-21 |
2012-04-24 |
Emd Millipore Corporation |
Purification of proteins
|
|
KR20090127326A
(ko)
*
|
2007-03-02 |
2009-12-10 |
와이어쓰 |
폴리펩티드의 생산을 위한 세포 배양물 중에서 구리 및 글루타메이트의 용도
|
|
AU2008232903B9
(en)
|
2007-03-30 |
2013-09-05 |
Medimmune Llc |
Antibodies with decreased deamidation profiles
|
|
TW200907059A
(en)
*
|
2007-03-30 |
2009-02-16 |
Abbott Lab |
Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
|
|
EP2508613A3
(en)
*
|
2007-04-03 |
2012-11-28 |
Oxyrane UK Limited |
Glycosylation of molecules
|
|
US20100113294A1
(en)
|
2007-04-16 |
2010-05-06 |
Momenta Pharmaceuticals, Inc. |
Defined glycoprotein products and related methods
|
|
TW200902708A
(en)
*
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
|
EP1988101A1
(en)
|
2007-05-04 |
2008-11-05 |
Novo Nordisk A/S |
Improvement of factor VIII polypeptide titers in cell cultures
|
|
WO2008135498A2
(en)
|
2007-05-04 |
2008-11-13 |
Novo Nordisk A/S |
Prevention of protein degradation in mammalian cell cultures
|
|
CA2687082C
(en)
|
2007-05-11 |
2014-01-14 |
Amgen Inc. |
Improved feed media
|
|
WO2008154014A2
(en)
*
|
2007-06-11 |
2008-12-18 |
Amgen Inc. |
A method for culturing mammalian cells to improve recombinant protein production
|
|
WO2009009523A2
(en)
*
|
2007-07-09 |
2009-01-15 |
Genentech, Inc. |
Prevention of disulfide bond reduction during recombinant production of polypeptides
|
|
EP3327132A3
(en)
|
2007-08-09 |
2018-07-18 |
Wyeth LLC |
Use of perfusion to enhance production of fed-batch cell culture in bioreactors
|
|
WO2009058769A1
(en)
|
2007-10-30 |
2009-05-07 |
Schering Corporation |
Purification of antibodies containing hydrophobic variants
|
|
CL2008003218A1
(es)
|
2007-10-30 |
2009-03-06 |
Genentech Inc |
Método para la purificación de un anticuerpo a partir de una composición que comprende el anticuerpo y al menos un contaminante.
|
|
TWM332870U
(en)
*
|
2007-11-22 |
2008-05-21 |
Delta Electronics Inc |
Side-edge type backlight module
|
|
TWI661833B
(zh)
*
|
2007-11-30 |
2019-06-11 |
百慕達商艾伯維生物技術有限責任公司 |
蛋白質調配物及製造其之方法
|
|
PL2235197T3
(pl)
|
2007-12-27 |
2018-01-31 |
Baxalta GmbH |
Sposoby hodowli komórek
|
|
EP2287174B8
(en)
*
|
2008-01-18 |
2016-12-07 |
Bio-Rad Laboratories, Inc. |
Enhanced purification of antibody fragments by apatite chromatography
|
|
WO2009114641A1
(en)
*
|
2008-03-11 |
2009-09-17 |
Genentech, Inc. |
Antibodies with enhanced adcc function
|
|
WO2009129226A1
(en)
*
|
2008-04-15 |
2009-10-22 |
Talecris Biotherapeutics, Inc. |
Two-stage ultrafiltration/diafiltration
|
|
CN102076865B
(zh)
*
|
2008-05-02 |
2016-03-16 |
西雅图基因公司 |
用于制造核心岩藻糖基化降低的抗体和抗体衍生物的方法和组合物
|
|
EP2331700A2
(en)
|
2008-08-08 |
2011-06-15 |
Biogen Idec MA Inc. |
Nutrient monitoring and feedback control for increased bioproduct production
|
|
KR101843915B1
(ko)
*
|
2008-08-14 |
2018-04-02 |
제넨테크, 인크. |
고유 단백질 대체 이온 교환 막 크로마토그래피를 이용한 오염물의 제거 방법
|
|
US8080415B2
(en)
|
2008-09-26 |
2011-12-20 |
Eureka Therapeutics, Inc. |
Modified host cells and uses thereof
|
|
NZ592097A
(en)
*
|
2008-10-20 |
2013-01-25 |
Abbott Lab |
Viral inactivation during purification of il-12 and il-18 antibodies
|
|
KR20110091678A
(ko)
*
|
2008-10-20 |
2011-08-12 |
아보트 러보러터리즈 |
단백질 ａ 친화성 크로마토그래피를 이용한 항체의 분리 및 정제
|
|
NZ592096A
(en)
|
2008-10-20 |
2013-01-25 |
Abbott Lab |
Antibodies that bind to il-12 and methods of purifying the same
|
|
EP2346901A1
(en)
|
2008-10-20 |
2011-07-27 |
Abbott Laboratories |
Antibodies that bind to il-18 and methods of purifying the same
|
|
EP2350130B1
(en)
*
|
2008-10-31 |
2018-10-03 |
Wyeth LLC |
Purification of acidic proteins using ceramic hydroxyapatite chromatography
|
|
US20110236391A1
(en)
*
|
2008-12-09 |
2011-09-29 |
Hanns-Christian Mahler |
Method for obtaining an excipient-free antibody solution
|
|
CA2745707A1
(en)
|
2008-12-22 |
2010-07-01 |
F. Hoffmann-La Roche Ag |
Immunoglobulin purification
|
|
EP2373676B1
(en)
|
2009-01-08 |
2017-04-19 |
GE Healthcare BioProcess R&D AB |
Separation method using single polymer phase systems
|
|
JP5728392B2
(ja)
|
2009-03-05 |
2015-06-03 |
バイオジェン アイデック エムエー インコーポレイティドＢｉｏｇｅｎ Ｉｄｅｃ Ｉｎｃ． |
免疫グロブリンの精製
|
|
US9056896B2
(en)
*
|
2009-03-27 |
2015-06-16 |
Asahi Kasei Medical Co., Ltd. |
Method for removing viruses from high concentration monoclonal antibody solution
|
|
WO2010120739A1
(en)
|
2009-04-13 |
2010-10-21 |
Bristol-Myers Squibb Company |
Protein purification by citrate precipitation
|
|
EP2421892A1
(en)
|
2009-04-20 |
2012-02-29 |
Pfizer Inc. |
Control of protein glycosylation and compositions and methods relating thereto
|
|
WO2010136515A1
(en)
*
|
2009-05-28 |
2010-12-02 |
Boehringer Ingelheim International Gmbh |
Method for a rational cell culturing process
|
|
WO2010141855A1
(en)
*
|
2009-06-05 |
2010-12-09 |
Momenta Pharmaceuticals, Inc. |
Methods of modulating fucosylation of glycoproteins
|
|
PL2451936T3
(pl)
|
2009-07-06 |
2020-02-28 |
F. Hoffmann-La Roche Ag |
Sposób hodowli komórek eukariotycznych
|
|
WO2011009623A1
(en)
|
2009-07-24 |
2011-01-27 |
F. Hoffmann-La Roche Ag |
Optimizing the production of antibodies
|
|
WO2011015926A1
(en)
|
2009-08-03 |
2011-02-10 |
Avesthagen Limited |
A process of fermentation, purification and production of recombinant soluble tumour necrosis factor alfa receptor (tnfr) - human igg fc fusion protein
|
|
KR101844859B1
(ko)
|
2009-08-06 |
2018-05-18 |
제넨테크, 인크. |
단백질 정제 시의 바이러스 제거의 개선방법
|
|
WO2011019622A1
(en)
*
|
2009-08-14 |
2011-02-17 |
Genentech, Inc. |
Cell culture methods to make antibodies with enhanced adcc function
|
|
WO2011024025A1
(en)
|
2009-08-28 |
2011-03-03 |
Avesthagen Limited |
An erythropoietin analogue and a method thereof
|
|
CA2772653C
(en)
|
2009-09-01 |
2019-06-25 |
Genentech, Inc. |
Enhanced protein purification through a modified protein a elution
|
|
US9540426B2
(en)
|
2009-10-06 |
2017-01-10 |
Bristol-Myers Squibb Company |
Mammalian cell culture processes for protein production
|
|
EP2490780A4
(en)
*
|
2009-10-20 |
2014-04-09 |
Merck Sharp & Dohme |
USE OF A MIXED MODE CHROMATOGRAPHY FOR THE DETECTION AND PURIFICATION OF BASIC ANTIBODY PRODUCTS
|
|
PL3037104T3
(pl)
*
|
2009-10-20 |
2020-11-16 |
Abbvie Inc. |
Izolacja i oczyszczanie przeciwciał anty-il-13 z zastosowaniem chromatografii powinowactwa z białkiem a
|
|
US9096879B2
(en)
|
2009-11-24 |
2015-08-04 |
Biogen Ma Inc. |
Method of supplementing culture media to prevent undesirable amino acid substitutions
|
|
WO2011069056A2
(en)
|
2009-12-04 |
2011-06-09 |
Momenta Pharmaceuticals, Inc. |
Antennary fucosylation in glycoproteins from cho cells
|
|
US8277649B2
(en)
|
2009-12-14 |
2012-10-02 |
General Electric Company |
Membranes and associated methods for purification of antibodies
|
|
JP5909450B2
(ja)
*
|
2009-12-18 |
2016-04-26 |
ノバルティス アーゲー |
洗浄溶液及びアフィニティークロマトグラフィーの方法
|
|
WO2011087301A2
(ko)
*
|
2010-01-15 |
2011-07-21 |
성균관대학교산학협력단 |
기체 및 수분 차단용 그래핀 보호막, 이의 형성 방법 및 그의 용도
|
|
KR20130048218A
(ko)
*
|
2010-04-06 |
2013-05-09 |
헬리아에 디벨롭먼트, 엘엘씨 |
조류의 탈수 및 그것으로부터의 물을 재사용하기 위한 방법 및 시스템
|
|
CA2794697A1
(en)
|
2010-04-07 |
2011-10-13 |
Momenta Pharmaceuticals, Inc. |
High mannose glycans
|
|
ES2533074T3
(es)
|
2010-04-26 |
2015-04-07 |
Novartis Ag |
Medio de cultivo celular mejorado
|
|
EP3862423A1
(en)
|
2010-04-26 |
2021-08-11 |
Novartis AG |
Improved cell cultivation process
|
|
RU2614125C2
(ru)
|
2010-05-28 |
2017-03-22 |
Дженентек, Инк. |
Снижение уровня лактата и увеличение продукции полипептида путем ингибирования экспрессии лактатдегидрогеназы и киназы пируватдегидрогеназы
|
|
SG187198A1
(en)
|
2010-08-05 |
2013-03-28 |
Amgen Inc |
Dipeptides to enhance yield and viability from cell cultures
|
|
WO2012030512A1
(en)
|
2010-09-03 |
2012-03-08 |
Percivia Llc. |
Flow-through protein purification process
|
|
BR112013006403A2
(pt)
*
|
2010-09-20 |
2015-09-29 |
Abbvie Inc |
purificação de anticorpos usando cromatografia de leito móvel simulado
|
|
SG10201508401TA
(en)
*
|
2010-10-11 |
2015-11-27 |
Abbvie Bahamas Ltd |
Processes for purification of proteins
|
|
KR101898302B1
(ko)
|
2010-10-15 |
2018-09-13 |
제이씨알 파마 가부시키가이샤 |
당사슬의 비환원 말단이 만노오스 잔기인 당 단백질의 제조 방법
|
|
EP2450375A1
(en)
|
2010-11-09 |
2012-05-09 |
Sandoz Gmbh |
Cell culture medium and process for protein expression, said medium and process comprising a PAM inhibitor
|
|
EP2649087A1
(en)
*
|
2010-12-08 |
2013-10-16 |
Amgen Inc. |
Ion exchange chromatography in the presence of an amino acid
|
|
MX357821B
(es)
|
2010-12-21 |
2018-07-25 |
Hoffmann La Roche |
Preparación de anticuerpo enriquecida con isoforma y método para obtenerla.
|
|
AU2012226398B9
(en)
|
2011-03-06 |
2017-04-13 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
|
MX2013010737A
(es)
|
2011-03-25 |
2014-03-12 |
Genentech Inc |
Novedosos metodos de purificacion de proteinas.
|
|
EP2511293A1
(en)
|
2011-04-13 |
2012-10-17 |
LEK Pharmaceuticals d.d. |
A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins
|
|
WO2012145682A1
(en)
|
2011-04-21 |
2012-10-26 |
Amgen Inc. |
A method for culturing mammalian cells to improve recombinant protein production
|
|
MY166973A
(en)
|
2011-04-29 |
2018-07-27 |
Biocon Res Limited |
Methods for reducing accumulation of lactate during culturing and method for producing polypeptide
|
|
US20120283419A1
(en)
|
2011-05-03 |
2012-11-08 |
Avantor Performance Materials, Inc. |
Separation of protein monomers from aggregates by solid weak anion exchange support functionalized with amine moieties
|
|
EP3388443A1
(en)
|
2011-05-13 |
2018-10-17 |
Biogen MA Inc. |
Methods of preventing and removing trisulfide bonds
|
|
WO2013006461A1
(en)
|
2011-07-01 |
2013-01-10 |
Biogen Idec Ma Inc. |
Cholesterol-based media supplementals for cell culture
|
|
HUE033279T2
(en)
|
2011-07-01 |
2017-11-28 |
Amgen Inc |
Mammalian cell culture
|
|
US9475858B2
(en)
|
2011-07-08 |
2016-10-25 |
Momenta Pharmaceuticals, Inc. |
Cell culture process
|
|
WO2013013013A2
(en)
|
2011-07-21 |
2013-01-24 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for producing modified glycoproteins
|
|
WO2013057078A1
(en)
|
2011-10-19 |
2013-04-25 |
Roche Glycart Ag |
Separation method for fucosylated antibodies
|
|
WO2013158279A1
(en)
*
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Protein purification methods to reduce acidic species
|
|
WO2013176754A1
(en)
*
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
|
US9085618B2
(en)
*
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|